[Cancer Research 65, 3336-3346, April 15, 2005]
© 2005 American Association for Cancer Research
Experimental Therapeutics, Molecular Targets, and Chemical Biology |
Synergistic Augmentation of Rapamycin-Induced Autophagy in Malignant Glioma Cells by Phosphatidylinositol 3-Kinase/Protein Kinase B Inhibitors
Hayato Takeuchi1,
Yasuko Kondo1,
Keishi Fujiwara1,
Takao Kanzawa1,
Hiroshi Aoki1,
Gordon B. Mills2 and
Seiji Kondo1,3
Departments of 1 Neurosurgery and 2 Molecular Therapeutics, University of Texas M.D. Anderson Cancer Center and 3 University of Texas Graduate School of Biomedical Science at Houston, Houston, Texas
Requests for reprints: Seiji Kondo, Department of Neurosurgery, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 64, Houston, TX 77030. Phone: 713-792-3526; Fax: 713-794-5514; E-mail: seikondo{at}mdanderson.org.
The mammalian target of rapamycin (mTOR) is a downstream effector of the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway and a central modulator of cell proliferation in malignant gliomas. Therefore, the targeting of mTOR signaling is considered a promising therapy for malignant gliomas. However, the mechanisms underlying the cytotoxic effects of a selective mTOR inhibitor, rapamycin, on malignant glioma cells are poorly understood. The purpose of this study was thus to elucidate how rapamycin exerts its cytotoxic effects on malignant glioma cells. We showed that rapamycin induced autophagy but not apoptosis in rapamycin-sensitive malignant glioma U87-MG and T98G cells by inhibiting the function of mTOR. In contrast, in rapamycin-resistant U373-MG cells, the inhibitory effect of rapamycin was minor, although the phosphorylation of p70S6 kinase, a molecule downstream of mTOR, was remarkably inhibited. Interestingly, a PI3K inhibitor, LY294002, and an Akt inhibitor, UCN-01 (7-hydroxystaurosporine), both synergistically sensitized U87-MG and T98G cells as well as U373-MG cells to rapamycin by stimulating the induction of autophagy. Enforced expression of active Akt in tumor cells suppressed the combined effects of LY294002 or UCN-01, whereas dominant-negative Akt expression was sufficient to increase the sensitivity of tumor cells to rapamycin. These results indicate that rapamycin exerts its antitumor effect on malignant glioma cells by inducing autophagy and suggest that in malignant glioma cells a disruption of the PI3K/Akt signaling pathway could greatly enhance the effectiveness of mTOR inhibitors.
This article has been cited by other articles:
|
|
|
|
 
M. Wang, W. Tan, J. Zhou, J. Leow, M. Go, H. S. Lee, and P. J. Casey
A Small Molecule Inhibitor of Isoprenylcysteine Carboxymethyltransferase Induces Autophagic Cell Death in PC3 Prostate Cancer Cells
J. Biol. Chem.,
July 4, 2008;
283(27):
18678 - 18684.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. H. Overmeyer, A. Kaul, E. E. Johnson, and W. A. Maltese
Active Ras Triggers Death in Glioblastoma Cells through Hyperstimulation of Macropinocytosis
Mol. Cancer Res.,
June 1, 2008;
6(6):
965 - 977.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Pan, S. Kondo, W. Le, and J. Jankovic
The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease
Brain,
January 10, 2008;
(2008)
awm318v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. A. Newman, Y. Kondo, T. Yokoyama, S. Dixon, C. Cartwright, D. Chan, M. Johansen, and Peiying Yang
Autophagic Cell Death of Human Pancreatic Tumor Cells Mediated by Oleandrin, a Lipid-Soluble Cardiac Glycoside
Integr Cancer Ther,
December 1, 2007;
6(4):
354 - 364.
[Abstract]
[PDF]
|
|
|
|
|
|
|
X. Q. Lun, H. Zhou, T. Alain, B. Sun, L. Wang, J. W. Barrett, M. M. Stanford, G. McFadden, J. Bell, D. L. Senger, et al.
Targeting Human Medulloblastoma: Oncolytic Virotherapy with Myxoma Virus Is Enhanced by Rapamycin
Cancer Res.,
September 15, 2007;
67(18):
8818 - 8827.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Aoki, E. Iwado, M. S. Eller, Y. Kondo, K. Fujiwara, G.-Z. Li, K. R. Hess, D. R. Siwak, R. Sawaya, G. B. Mills, et al.
Telomere 3' overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells
FASEB J,
September 1, 2007;
21(11):
2918 - 2930.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A M Lobascio, F G Klinger, M L Scaldaferri, D Farini, and M De Felici
Analysis of programmed cell death in mouse fetal oocytes
Reproduction,
August 1, 2007;
134(2):
241 - 252.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Ohtani, A. Iwamaru, W. Deng, K. Ueda, G. Wu, G. Jayachandran, S. Kondo, E. N. Atkinson, J. D. Minna, J. A. Roth, et al.
Tumor Suppressor 101F6 and Ascorbate Synergistically and Selectively Inhibit Non-Small Cell Lung Cancer Growth by Caspase-Independent Apoptosis and Autophagy
Cancer Res.,
July 1, 2007;
67(13):
6293 - 6303.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Aoki, Y. Takada, S. Kondo, R. Sawaya, B. B. Aggarwal, and Y. Kondo
Evidence That Curcumin Suppresses the Growth of Malignant Gliomas in Vitro and in Vivo through Induction of Autophagy: Role of Akt and Extracellular Signal-Regulated Kinase Signaling Pathways
Mol. Pharmacol.,
July 1, 2007;
72(1):
29 - 39.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. F. Petricoin III, V. Espina, R. P. Araujo, B. Midura, C. Yeung, X. Wan, G. S. Eichler, D. J. Johann Jr., S. Qualman, M. Tsokos, et al.
Phosphoprotein Pathway Mapping: Akt/Mammalian Target of Rapamycin Activation Is Negatively Associated with Childhood Rhabdomyosarcoma Survival
Cancer Res.,
April 1, 2007;
67(7):
3431 - 3440.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Akar, B. Ozpolat, K. Mehta, J. Fok, Y. Kondo, and G. Lopez-Berestein
Tissue Transglutaminase Inhibits Autophagy in Pancreatic Cancer Cells
Mol. Cancer Res.,
March 1, 2007;
5(3):
241 - 249.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Iwamaru, E. Iwado, S. Kondo, R. A. Newman, B. Vera, A. D. Rodriguez, and Y. Kondo
Eupalmerin acetate, a novel anticancer agent from Caribbean gorgonian octocorals, induces apoptosis in malignant glioma cells via the c-Jun NH2-terminal kinase pathway
Mol. Cancer Ther.,
January 1, 2007;
6(1):
184 - 192.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Kessel, J. J. Reiners Jr., S. T. Hazeldine, L. Polin, and J. P. Horwitz
The role of autophagy in the death of L1210 leukemia cells initiated by the new antitumor agents, XK469 and SH80
Mol. Cancer Ther.,
January 1, 2007;
6(1):
370 - 379.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P.-L. Kuo, Y.-L. Hsu, and C.-Y. Cho
Plumbagin induces G2-M arrest and autophagy by inhibiting the AKT/mammalian target of rapamycin pathway in breast cancer cells
Mol. Cancer Ther.,
December 1, 2006;
5(12):
3209 - 3221.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Cao, T. Subhawong, J. M. Albert, K. W. Kim, L. Geng, K. R. Sekhar, Y. J. Gi, and B. Lu
Inhibition of Mammalian Target of Rapamycin or Apoptotic Pathway Induces Autophagy and Radiosensitizes PTEN Null Prostate Cancer Cells.
Cancer Res.,
October 15, 2006;
66(20):
10040 - 10047.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Herman-Antosiewicz, D. E. Johnson, and S. V. Singh
Sulforaphane Causes Autophagy to Inhibit Release of Cytochrome c and Apoptosis in Human Prostate Cancer Cells
Cancer Res.,
June 1, 2006;
66(11):
5828 - 5835.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Ito, H. Aoki, F. Kuhnel, Y. Kondo, S. Kubicka, T. Wirth, E. Iwado, A. Iwamaru, K. Fujiwara, K. R. Hess, et al.
Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus.
J Natl Cancer Inst,
May 3, 2006;
98(9):
625 - 636.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. N. Hait, S. Jin, and J.-M. Yang
A Matter of Life or Death (or Both): Understanding Autophagy in Cancer.
Clin. Cancer Res.,
April 1, 2006;
12(7):
1961 - 1965.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Wu, J.-M. Yang, S. Jin, H. Zhang, and W. N. Hait
Elongation factor-2 kinase regulates autophagy in human glioblastoma cells.
Cancer Res.,
March 15, 2006;
66(6):
3015 - 3023.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Zeng, J. H. Overmeyer, and W. A. Maltese
Functional specificity of the mammalian Beclin-Vps34 PI 3-kinase complex in macroautophagy versus endocytosis and lysosomal enzyme trafficking
J. Cell Sci.,
January 15, 2006;
119(2):
259 - 270.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Han, F. R. Khuri, and J. Roman
Fibronectin Stimulates Non-Small Cell Lung Carcinoma Cell Growth through Activation of Akt/Mammalian Target of Rapamycin/S6 Kinase and Inactivation of LKB1/AMP-Activated Protein Kinase Signal Pathways
Cancer Res.,
January 1, 2006;
66(1):
315 - 323.
[Abstract]
[Full Text]
[PDF]
|
|
|
Copyright © 2005 by the American Association for Cancer Research.
